US drug regulator inspects Sun Pharmaceutical's Halol plant in Gujarat

Sun Pharmaceutical Industries’ Halol plant in Gujarat, which was cleared in June by the US drug regulator, has been undergoing a fresh inspection, sources claimed.  The company declined to comment on the matter. Analysts said that while it could be a surprise audit (given the plant’s history of regulatory issues), it could also be a pre-approval inspection (that usually happens before a product from that site is approved by the US drug regulator). Sources claimed a team of inspectors from the US Food and Drug Administration (USFDA) was at the facility to inspect the plan.....

Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber?

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.

Most Read

Top Stories

Markets

Companies

Opinion

Latest News

Todays Paper

News you can use

Outbrain